All In Biotech

Drug Trial Radar · NCT07080385

Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

A Phase 2/3, Multicenter, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Last checked: Nov 20, 2026Latest source record: Apr 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

28

Planned (sponsor's estimate)

Start

Jan 30, 2026

Primary completion

Dec 2028

Study completion Dec 2030

Sponsor

Sponsor type
Industry
First posted
Jul 23, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 0 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The overall objective of this study is to evaluate the pharmacokinetics (PK), efficacy, and safety of encaleret in pediatric participants from birth to 17 years of age with ADH1.

Conditions

  • Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Interventions

  • EncaleretDrug

    Oral tablets, age-appropriate pediatric formulation (currently under development).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Period 1: Maximum Plasma Concentration (Cmax) of Encaleret and Metabolites M1, and M3Time frame: 5 days
  2. Period 1: Area Under the Plasma Concentration-time Curve (AUC) of Encaleret and Metabolites M1, and M3Time frame: 5 days
  3. Period 3: Number of Participants with Albumin-corrected Blood Calcium (cCa) and Urinary Calcium (UCa) Excretion ResponseTime frame: Week 25

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Yale University

    New Haven, Connecticut · Recruiting

  • Children's National Medical Center

    Washington D.C., District of Columbia · Recruiting

  • Nemours Children's Health

    Jacksonville, Florida · Recruiting

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania · Recruiting

  • Royal London Hospital

    London, United Kingdom · Recruiting

  • Royal Manchester Children's Hospital

    Manchester, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.